US2010160427A1PendingUtilityA1
Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents
Est. expiryJun 27, 2023(expired)· nominal 20-yr term from priority
Inventors:Ezio Bombardelli
A61P 9/10A61P 9/08A61P 3/06A61P 9/00A61P 9/14A61P 3/02A23L 33/10A61K 31/01A61K 31/355A61K 31/045A23L 33/105A23L 33/115A61K 31/20
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Combinations of vasoprotective agents useful for the prevention and the treatment of vascular injuries induced by an excess of plasma lipids comprising polycosanols, tocotriends and/or lycopene, procyanidole oligomers and vegetable oil rich in insaturated fatty acids.
Claims
exact text as granted — not AI-modified1 . A method for treating vascular injuries induced by an excess of plasma lipids, comprising administering to a subject in need thereof a combination of an effective amount of:
one or more polycosanols or esters thereof, either pure or as extracts; at least one of tocotrienol and lycopene; one or more procyanidole oligomers optionally complexed with phospholipids; and a vegetable oil rich in ω-3, ω-6 unsaturated fatty acids, wherein the composition is a pharmaceutical, dietetic or nutritional composition.
2 . The method as claimed in claim 1 , wherein the vegetable oil is selected from Enothera biennis, Ribes nigrum and Portulaca oleracea oil.
3 . The method as claimed in claim 2 , wherein the vegetable oil is Enothera biennis oil.
4 . The method as claimed in claim 1 , wherein the composition further comprises luteolin or a 7,3′, 4′-hydroxyethyl derivative thereof.
5 . The method as claimed in claim 1 , wherein the composition comprises polycosanol esters, wherein the polycosanol esters are polycosanols esterified with ferulic acid or other substituted cinnamates.
6 . The method as claimed in claim 1 , wherein the composition comprises procyanidole oligomers derived from the group consisting of Vitis vinifera, Camellia sinesis, Aesculus hippocastanum, and Olea europa.
7 . The method as claimed in claim 1 , wherein the composition comprises 5 to 30 mg of polycosanols, 1 to 50 mg of tocotrienol or lycopene, 100 to 320 mg of proanthocyanidins complexed with phospholipids, and 150 to 300 mg of vegetable oil, per unitary dosage form.
8 . The method as claimed in claim 1 , wherein the composition comprises tocotrienol.
9 . The method as claimed in claim 1 , wherein the vascular injuries induced by an excess of plasma lipids is hyperlipidemia with carotid plaques.Join the waitlist — get patent alerts
Track US2010160427A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.